|
STRADB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.836700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.80739999999991E-05 |
| Normal-vs-Stage2 |
9.362500E-02 |
| Normal-vs-Stage3 |
2.432800E-01 |
| Normal-vs-Stage4 |
7.486400E-01 |
| Stage1-vs-Stage2 |
1.503590E-03 |
| Stage1-vs-Stage3 |
2.920200E-03 |
| Stage1-vs-Stage4 |
9.808400E-02 |
| Stage2-vs-Stage3 |
5.842400E-01 |
| Stage2-vs-Stage4 |
5.005200E-01 |
| Stage3-vs-Stage4 |
6.544400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.164900E-04 |
| Normal-vs-AfricanAmerican |
3.964100E-04 |
| Normal-vs-Asian |
9.806600E-01 |
| Caucasian-vs-AfricanAmerican |
5.812200E-01 |
| Caucasian-vs-Asian |
2.556600E-01 |
| AfricanAmerican-vs-Asian |
2.968400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.211190E-04 |
| Normal-vs-Female |
1.419390E-03 |
| Male-vs-Female |
2.216400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.622500E-03 |
| Normal-vs-Extreme_Weight |
3.65210000000671E-05 |
| Normal-vs-Obese |
2.551000E-04 |
| Normal-vs-Extreme_Obese |
5.899900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.298200E-02 |
| Normal_Weight-vs-Obese |
3.780200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.408600E-01 |
| Extreme_Weight-vs-Obese |
2.613200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.306750E-01 |
| Obese-vs-Extreme_Obese |
4.558600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.912170E-01 |
| Normal-vs-Age(41-60Yrs) |
1.000390E-04 |
| Normal-vs-Age(61-80Yrs) |
6.07219999999575E-05 |
| Normal-vs-Age(81-100Yrs) |
1.338450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.592790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.161600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.632400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.711700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.752600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.828600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87901999999518E-05 |
| Normal-VS-Type2 PRCC |
1.549560E-01 |
| Normal-VS-KIRP CIMP |
4.548600E-01 |
| Normal-VS-Unclassified PRCC |
6.621900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.62960000005263E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.5428000000044E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.342100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.721000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.777500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.045900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.221500E-02 |
| Normal-vs-N1 |
9.335000E-01 |
| Normal-vs-N2 |
6.742800E-01 |
| N0-vs-N1 |
6.973700E-02 |
| N0-vs-N2 |
6.263800E-01 |
| N1-vs-N2 |
7.318400E-01 |
|
|
